Pathstone Family Office’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $1.43M | Buy |
|
|||||
|
2023
Q2 | $455K | Buy |
|
|||||
|
2023
Q1 | $366K | Sell |
|
|||||
|
2022
Q4 | $1.37M | Buy |
|
|||||
|
2022
Q3 | $1.3M | Buy |
|
|||||
|
2022
Q2 | $349K | Buy |
|
|||||
|
2022
Q1 | $325K | Buy |
|
|||||
|
2021
Q4 | $365K | Buy |
|
|||||
|
2021
Q3 | $251K | Sell |
|
|||||
|
2021
Q2 | $311K | Buy |
|
|||||
|
2021
Q1 | $226K | Buy |
|
|||||
|
2020
Q4 | $137K | Buy |
|
|||||
|
2020
Q3 | $128K | Hold |
|
|||||
|
2020
Q2 | $122K | Sell |
|
|||||
|
2020
Q1 | $244K | Buy |
|
|||||
|
2019
Q4 | $496K | Hold |
|
|||||
|
2019
Q3 | $39K | Hold |
|
|||||
|
2019
Q2 | $39K | Sell |
|
|||||
|
2019
Q1 | $124K | Buy |
|
|||||
|
2018
Q4 | $155K | Hold |
|
|||||
|
2018
Q3 | $182K | Buy |
|
|||||
|
2018
Q2 | $136K | Sell |
|
|||||
|
2018
Q1 | $142K | Buy |
|
|||||
|
2017
Q4 | $117K | Sell |
|
|||||
|
2017
Q3 | $120K | Sell |
|
|||||
|
2017
Q2 | $153K | Buy |
|
|||||
|
2017
Q1 | $102K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $115K | Hold |
|
|||||
|
2016
Q2 | $88K | Hold |
|
|||||
|
2016
Q1 | $95K | Buy |
|
|||||
|
2015
Q4 | $17K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $37K | Buy |
|